3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
17
Phase 3
3
Phase EARLY_PHASE1
1
Phase 4
1
Phase 2
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
6
Genitourinary
5
Gastrointestinal
5
Lymphoid
4
Thoracic
2
Sarcoma
2
Other
2
Head & Neck
2
Plasma cell
1
Other hematologic neoplasm
1
Gynecologic
1
Endocrine
1
Conditions
Uterine Cervical Neoplasms
35
Ovarian Neoplasms
31
Endometrial Neoplasms
13
Uterine Cervical Dysplasia
10
Papillomavirus Infections
9
Breast Neoplasms
9
Uterine Neoplasms
7
Ovarian Cysts
6
Lung Neoplasms
6
Stomach Neoplasms
4
Neoplasms
4
Esophageal Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Polycystic Ovary Syndrome
3
Ovarian Hyperstimulation Syndrome
3
Liver Neoplasms
3
Leiomyoma
3
Head and Neck Neoplasms
3
Carcinoma, Renal Cell
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Vomiting
2
Uterine Diseases
2
Urinary Bladder Neoplasms
2
Tobacco Use Disorder
2
Squamous Intraepithelial Lesions
2
Small Cell Lung Carcinoma
2
Recurrence
2
Peritoneal Neoplasms
2
Pancreatic Neoplasms
2
Interventions
Naproxen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Pain
×
Gynecologic
×
Clear all
NCT04145518
2025-12-12
MCUP
Endeavor Health
Phase 4
Completed
183 enrolled